Goldman Sachs Group Inc Matinas Bio Pharma Holdings, Inc. Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

May 14, 2024
BUY
$0.46 - $42.69 $16,193 - $1.5 Million
35,203 New
35,203 $17,000
Q4 2022

Feb 13, 2023
BUY
$0.46 - $42.69 $16,193 - $1.5 Million
35,203 New
35,203 $17,000
Q1 2022

May 16, 2022
SELL
$0.5 - $1.06 $23,228 - $49,244
-46,457 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$0.92 - $1.22 $42,740 - $56,677
46,457 New
46,457 $47,000

Others Institutions Holding MTNB

# of Institutions
6
Shares Held
3.52M
Call Options Held
0
Put Options Held
0
View Full List

About Matinas BioPharma Holdings, Inc.

MTNB Quotes by TradingView
  • Ticker MTNB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,864,992
  • Market Cap $130M
  • Description
  • Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...
More about MTNB
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email